Janet Napolitano, Director at Vir Biotechnology, Inc. (VIR), sold 12,190 shares at $7.80 ($95K) on 2024-09-09, disclosed to the SEC on 2024-09-10.
Scheduled sale ($95k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VIR | SELL | 2025-06-02 | $16K | — | Filing → |
| ZM | SELL | 2024-10-11 | $621K | — | Filing → |
| VIR | SELL | 2021-12-02 | $133K | — | Filing → |